Redox‐Responsive Polymeric Nanoparticle for Nucleic Acid Delivery and Cancer Therapy: Progress, Opportunities, and Challenges
Macromolecular Bioscience · 2024-03 · 24 (3)
DOI: 10.1002/mabi.202300238 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Macromolecular Bioscience, online erschienen am 22.10.2023. Verfasst von Lei Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medica…. Hauptthemen laut MEDLINE: Nucleic Acids, Neoplasms, Nanoparticles. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 401 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Guangdong Science and Technology Department, Guangzhou Science and Technology Bureau.
Abstract (Originalsprache)
Cancer development and progression of cancer are closely associated with the activation of oncogenes and loss of tumor suppressor genes. Nucleic acid drugs (e.g., siRNA, mRNA, and DNA) are widely used for cancer therapy due to their specific ability to regulate the expression of any cancer‐associated genes. However, nucleic acid drugs are negatively charged biomacromolecules that are susceptible to serum nucleases and cannot cross cell membrane. Therefore, specific delivery tools are required to facilitate the intracellular delivery of nucleic acid drugs. In the past few decades, a variety of nanoparticles (NPs) are designed and developed for nucleic acid delivery and cancer therapy. In particular, the polymeric NPs in response to the abnormal redox status in cancer cells have garnered much more attention as their potential in redox‐triggered nanostructure dissociation and rapid intracellular release of nucleic acid drugs. In this review, the important genes or signaling pathways regulating the abnormal redox status in cancer cells are briefly introduced and the recent development of redox‐responsive NPs for nucleic acid delivery and cancer therapy is systemically summarized. The future development of NPs‐mediated nucleic acid delivery and their challenges in clinical translation are also discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen Universi…
- Guangzhou Key Laboratory of Medical Nanomaterials, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, P. R. China.
- Nanhai Translational Innovation Center of Precision Immunology, Sun Yat-Sen Memorial Hospital, Foshan, 528200, P. R. China.
- The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, P. R. China.
ORCID-Profile: Xiaoding Xu
Förderung
- National Natural Science Foundation of China
- Guangdong Science and Technology Department
- Guangzhou Science and Technology Bureau
- Key Research and Development Program of Hunan Province of China
- Hunan Science and Technology Department
- High-level Talent Special Funding Scheme of Sun Yat-Sen Memorial Hospital
- Guangdong Provincial Department of Science and Technology
Zitieren
APA
Xu, L., Cao, Y., Xu, Y., Li, R., & Xu, X. (2024). Redox‐Responsive Polymeric Nanoparticle for Nucleic Acid Delivery and Cancer Therapy: Progress, Opportunities, and Challenges. Macromolecular Bioscience, 24(3). https://doi.org/10.1002/mabi.202300238
Vancouver
Xu L, Cao Y, Xu Y, Li R, Xu X. Redox‐Responsive Polymeric Nanoparticle for Nucleic Acid Delivery and Cancer Therapy: Progress, Opportunities, and Challenges. Macromolecular Bioscience. 2024;24(3). doi:10.1002/mabi.202300238
BibTeX
@article{Xu2024,
author = {Xu, Lei and Cao, Yuan and Xu, Ya and Li, Rong and Xu, Xiaoding},
title = {Redox‐Responsive Polymeric Nanoparticle for Nucleic Acid Delivery and Cancer Therapy: Progress, Opportunities, and Challenges},
journal = {Macromolecular Bioscience},
year = {2024},
volume = {24},
number = {3},
doi = {10.1002/mabi.202300238}
}
EUVIMED